Products for Research Use Only
RegisterLogin

VY-3-135

CAT: 0013-GTR19166797-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19166797-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
VY-3-135 is a potent and selective oral ACSS2 inhibitor (IC50 = 44 nM) with no activity against ACSS1/ACSS3. It effectively blocks ACSS2-dependent fatty acid metabolism in vitro and in vivo, making it a valuable tool for researching cancer metabolism and metabolic disorders.
CAS Number
1824637-41-3
Product Name Alternative
Breast cancer, ACSS2, Inhibitor, FattyAcidSynthase, Fatty Acid Synthase, inhibit, orally active, stable ACSS2 inhibitor, VY3135, VY-3-135, VY 3 135
Field of Research
Metabolism Research
Purity
98.00% (May vary between batches)
Solubility
DMSO:46.67 mg/mL (108.66 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (4.66 mM)
Smiles
CCn1c (nc2ccc (cc12) C (=O) NC[C@@H] (C) O) C (O) (c1ccccc1) c1ccccc1
Molecular Formula
C26H27N3O3
Molecular Weight
429.51
Storage Conditions
-20°C
Notes
For research use only.

Related Products

CatalogName
GTR19210474-01MP-135
GTR19208570-01S 135
GTR19211061-01OL-135
GTR19204868-01WY-135
GTR19195782-01AK-135
GTR19241379-01EGFR-IN-135
GTR19274881-01BMS-135
GTR19155837-01AES-135
GTR19177620-01AES-135
GTR19210458-01PGL-135

Alternative Products

CatalogName
MBS3617377-01VY-3-135
pro-370CALM2 135 a.a.
BA8696-25BIP-135
B6928-10LE 135
NLD06083-01WY-135
LUD65961-01AES-135
T69546-01MP-135
HY-168627EGFR-IN-135

Popular Products